217 related articles for article (PubMed ID: 29659579)
1. Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
Takayama-Ito M; Lim CK; Yamaguchi Y; Posadas-Herrera G; Kato H; Iizuka I; Islam MT; Morimoto K; Saijo M
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006398. PubMed ID: 29659579
[TBL] [Abstract][Full Text] [Related]
2. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK
PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.
Steffensen MA; Holst PJ; Steengaard SS; Jensen BA; Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
J Virol; 2013 Jun; 87(11):6283-95. PubMed ID: 23536658
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.
Lee J; Hashimoto M; Im SJ; Araki K; Jin HT; Davis CW; Konieczny BT; Spies GA; McElrath MJ; Ahmed R
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003483
[TBL] [Abstract][Full Text] [Related]
5. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
6. HLA-A2-restricted protection against lethal lymphocytic choriomeningitis.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Ting JP; Bui HH; Sette A; Buchmeier MJ
J Virol; 2007 Mar; 81(5):2307-17. PubMed ID: 17166907
[TBL] [Abstract][Full Text] [Related]
7. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
Hashizume M; Takashima A; Iwasaki M
J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
[TBL] [Abstract][Full Text] [Related]
8. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.
Blass E; Aid M; Martinot AJ; Larocca RA; Kang ZH; Badamchi-Zadeh A; Penaloza-MacMaster P; Reeves RK; Barouch DH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514912
[TBL] [Abstract][Full Text] [Related]
10. Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.
Iwasaki M; Ng CT; Cubitt B; de la Torre JC
J Virol; 2016 Nov; 90(22):10102-10112. PubMed ID: 27581982
[TBL] [Abstract][Full Text] [Related]
11. Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization.
Hassett DE; Slifka MK; Zhang J; Whitton JL
J Virol; 2000 Sep; 74(18):8286-91. PubMed ID: 10954526
[TBL] [Abstract][Full Text] [Related]
12. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
Holst PJ; Christensen JP; Thomsen AR
J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
[TBL] [Abstract][Full Text] [Related]
15. Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.
Castrucci MR; Hou S; Doherty PC; Kawaoka Y
J Virol; 1994 Jun; 68(6):3486-90. PubMed ID: 7514676
[TBL] [Abstract][Full Text] [Related]
16. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
17. Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice.
Grujic M; Holst PJ; Christensen JP; Thomsen AR
J Gen Virol; 2009 Feb; 90(Pt 2):414-422. PubMed ID: 19141451
[TBL] [Abstract][Full Text] [Related]
18. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus.
Goossens PL; Milon G; Cossart P; Saron MF
Int Immunol; 1995 May; 7(5):797-805. PubMed ID: 7547706
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity.
Shen H; Slifka MK; Matloubian M; Jensen ER; Ahmed R; Miller JF
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3987-91. PubMed ID: 7732018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]